| 注册
首页|期刊导航|中国药业|血必净注射液联合抗生素治疗重症肺炎36例临床观察

血必净注射液联合抗生素治疗重症肺炎36例临床观察

张伟 谢辉 张震环

中国药业2017,Vol.26Issue(17):57-58,2.
中国药业2017,Vol.26Issue(17):57-58,2.DOI:10.3969/j.issn.1006-4931.2017.17.019

血必净注射液联合抗生素治疗重症肺炎36例临床观察

Clinical Observation of Xuebijing Injection Combined with Antibiotics for Treating Severe Pneumonia in 36 Cases

张伟 1谢辉 1张震环1

作者信息

  • 1. 南京明基医院重症医学科,江苏南京 210019
  • 折叠

摘要

Abstract

Objective To investigate the clinical effect of Xuebijing Injection combined with antibiotics in the treatment of severe pneu-monia. Methods A total of 36 patients with severe pneumonia in our hospital were randomly divided into the control group and the treatment group, 18 cases in each group. The control group was treated with antibiotics, the treatment group was treated with Xuebijing Injection combined with antibiotics. After 2 weeks of continuous treatment, the therapeutic effects of the two groups were com-pared. Results The total effective rate of the treatment group was 94. 44%, which was significantly higher than 66. 67% of the control group ( P < 0. 05 ) . The white blood cell counts ( WBC ) , carbon dioxide partial pressure ( PCO2 ) , partial pressure of oxygen ( PO2 ) between the two groups were significantly different ( P < 0. 05 ) . Conclusion Xuebijing Injection combined with antibiotics in the treatment of severe pneumonia can improve the pulmonary function, reduce inflammatory factor in serum, and it has high curative effect, which is worthy of clinical promotion.

关键词

血必净注射液/抗生素/重症肺炎/疗效/肝功能/炎性因子

Key words

Xuebijing Injection/antibiotics/severe pneumonia/curative effect/pulmonary function/inflammatory factors

分类

医药卫生

引用本文复制引用

张伟,谢辉,张震环..血必净注射液联合抗生素治疗重症肺炎36例临床观察[J].中国药业,2017,26(17):57-58,2.

中国药业

OACSTPCD

1006-4931

访问量1
|
下载量0
段落导航相关论文